Table 4 Characteristics of the patients
pre-CPDX screening (n = 63) | CPDX screening (n = 84) | p-value | |
|---|---|---|---|
Age (year), median [IQR] | 77 [67.00–85.50] | 78 [71.00–85.00] | 0.793 |
Sex Male, n (%) | 28 (44.4) | 45 (53.6) | 0.319 |
Microorganism, n (%) | 0.214 | ||
Escherichia coli | 52 (82.5) | 76 (90.5) | |
Klebsiella pneumoniae | 11 (17.5) | 8 (9.5) | |
Hospital-acquired, n (%) | 24 (38.1) | 26 (31.0) | 0.384 |
Pitt bacteremia score, median [IQR] | 1.00 [1.00–3.00] | 1.00 [0.00–3.00] | 0.903 |
≥ 2, n (%) | 27 (42.9) | 43 (51.2) | 0.404 |
Admitted to ICU, n (%) | 1 (1.6) | 3 (3.6) | 0.635 |
Surgical service, n (%) | 1 (1.6) | 5 (6.0) | 0.238 |
Time to positive blood culture report from blood culture collection (h), median [IQR] | 18.29 [15.66–21.30] | 18.55 [14.93–22.58] | 0.798 |
Susceptible initial antimicrobial agent before blood culture positive report, n (%) | 28 (44.4) | 39 (46.4) | 0.868 |
Duration of intravenous antibiotic therapy (days), median [IQR] | 10.00 [7.00–14.00] | 8.50 [6.00–13.00] | 0.380 |
Charlson comorbidity index, median [IQR] | 2.00 [1.00–4.00] | 2.00 [1.00–4.00] | 0.365 |
Source of bacteremia, n (%) | |||
Urinary tract | 39 (61.9) | 55 (65.5) | |
Intra-abdominal | 12 (19.0) | 18 (21.4) | |
Respiratory | 3 (4.8) | 1 (1.2) | |
Others | 1 (1.6) | 2 (2.4) | |
Unknown | 8 (12.7) | 8 (9.5) | |